I

IBEX

Biotech company: antibodies and gene therapy

Senior Network Engineer

Full-TimeUpdated on 10/15/2026Deadline 10/5/27
No salary listed
Mid, Senior
Bachelor's, Master's
Karachi, Karachi City, Sindh, Pakistan
In Person
IT OperationsNetwork Engineering & Administration

About the job

Requirements
  • A Master's or Bachelor's degree in Computer Science or Engineering is required.
  • Four to five years of experience with WAN protocols (BGP, EIGRP, OSPF), LAN/WLAN (DNS, IP addressing, QoS, Spanning Tree, Multicast), Cisco Catalyst switches, and Cisco ISR/ASR routers is required.
  • Knowledge of next-generation firewalls across multiple vendors, including Cisco ASA, Palo Alto, and FortiGate, and security products and practices such as access control lists, firewalls, and virtual private networks is required.
  • Familiarity with wireless access controllers and access points is required.
  • Project experience implementing core infrastructure, networking, and cloud-based services for business teams or consumers is required.
  • Experience with software-defined networking/software-defined wide area networking, public cloud, and security products and practices such as access control lists, firewalls, and virtual private networks is required.
  • Expertise in troubleshooting routing, switching, and virtual private networks, and a strong understanding of WAN and internet multi-homing architecture are required.
  • Experience with security audits, network patching and upgrades, and compliance with network security policies is required.
  • Knowledge of Information Technology Infrastructure Library practices and enterprise change management processes is required.
  • Operational excellence with a solid understanding of Information Technology Infrastructure Library practices is required.
  • Strong experience with next-generation firewalls across multiple vendors, including Cisco ASA, Palo Alto, and FortiGate, is required.
  • Proficiency with Cisco IOS, Cisco ASA/Palo Alto firewalls, Fortinet Wireless, SolarWinds, and other network management tools is required.
  • Team management experience is required.
Responsibilities
  • Troubleshoot and provide Tier 1, Tier 2, and Tier 3 support to diagnose and resolve escalated issues that may cause service degradation or connectivity interruptions across the data center, disaster recovery site, regional hubs, and branches.
  • Manage and maintain network infrastructure, handling new tasks independently.
  • Perform routine network maintenance and system upgrades.
  • Monitor network performance to ensure system availability and reliability.
  • Track resource utilization, analyze trends, and support capacity planning.
  • Follow established configuration and change management policies to ensure change awareness, proper approvals, and successful implementation.
  • Define and implement network security rules, policies, and procedures in collaboration with the security team.
  • Liaise with internal and external teams to resolve issues efficiently.
  • Handle network-related queries from operations and end users.
  • Maintain network tools and applications such as SolarWinds Orion, terminal access controller access-control system (TACACS), and configuration backup systems.
  • Join incident bridges, manage trouble tickets, and respond to real-time network queries.
  • Coordinate with telecommunications and carrier service providers as needed.
  • Configure and install network devices and services, including routers, switches, firewalls, and virtual private networks.

About the company

Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.

Company Size

1-10

Company Stage

Early VC

Total Funding

$4.2M

Headquarters

North Bethesda, Maryland

Founded

2015

Get referred to IBEX

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ibex keeps an open 506(c) offering, signaling active capital formation in 2026.
  • The 2022 CD147 patent supports oncology and inflammation licensing conversations.
  • Anti-MIF VHH development continues, with animal-model testing already disclosed.

What critics are saying

  • Ibex has no disclosed commercial products, leaving revenue dependent on financing.
  • The open Regulation D offering implies dilution risk and financing pressure through 2026.
  • Without clinical validation, the company risks becoming a perpetual patent shop.

What makes IBEX unique

  • North Bethesda-based Ibex Biosciences focuses on antibody, gene-therapy, and stem-cell programs.
  • Its 2026 pipeline spans CD147 antibodies, anti-MIF VHHs, and PCBP1 stem-cell methods.
  • Ibex still controls early patentable assets, including 2022 CD147 publication.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus

Company News

Ibex Innovations
Mar 12th, 2025
IBEX Completes £2m Fundraise for Osteoporosis

IBEX has successfully completed a £2 million funding round to advance its mission of using X-ray technology to diagnose osteoporosis early. The company aims to shift from reactive to proactive treatment of this silent disease. With partnerships established with X-ray and mammography OEMs in 2024, IBEX plans to deploy its technology in clinical settings by 2025, demonstrating cost savings for the NHS.

Globes
Feb 8th, 2022
Gauzy acquires Vision Systems

Israeli light control nanotech and smart glass company Gauzy has announced that it has acquired French company Vision Systems, which develops ADAS (Advanced Driver Assistance System) and shading solutions for the aeronautic, land transport, and marine industries.